Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Fabrice Berna, MD, PhD
JCP
Article
Extrapyramidal Side Effects and Antipsychotics
January 8, 2019
Extrapyramidal side effects have been identified as frequent side effects of antipsychotics in RCTs with highly selected subjects, but how common are they in nonselected samples? This national multicenter...
David Misdrahi
,
Arnaud Tessier
,
Antoine Daubigney
, et al
JCP
Original Research
Metabolic Syndrome Predicts Relapse in Schizophrenia
September 18, 2018
Cardiovascular diseases are the primary cause of mortality in individuals with schizophrenia, yet no study has yet explored the impact of metabolic syndrome on schizophrenia relapse. This study explored...
Ophelia Godin
,
Marion Leboyer
,
Frank Schürhoff
, et al
JCP
Original Research
Mediators Between Insight and Suicidality in Schizophrenia
April 17, 2018
The relationship between insight and suicide in patients with schizophrenia is unclear. Read this article to learn the extent to which that relationship may be influenced by quality of...
Paul Roux
,
David Misdrahi
,
Delphine Capdevielle
, et al
JCP
Original Research
Self-Reported Medication Adherence in Schizophrenia
September 28, 2016
Medication nonadherence among schizophrenia patients is common, but also possibly modifiable. Learn about how a patient self-report instrument—the MARS—can be used to identify nonadherence in these patients.
David Misdrahi
,
Arnaud Tessier
,
Joel Swendsen
, et al
